Here is some good news from a little company, I think it is a pretty good bet that they will some nice revenues in a year or two. At .035 or .04 these share are a good speculation for short term gain or long term growth.
Biosign Begins Sales Effort In the United States
24 Jun 2013 17:12 ET
ACCESSWIRE
TORONTO, ONTARIO, June 24th, 2013 - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") made the following statement:
US SALES BEGIN
Biosign is pleased to announce sales of both Pulsewave Health Monitors and Healthanywhere patient monitoring software and services to US customers. Effective immediately, the US Medical Device Establishment listing for Biosign and the Medical Device Product listings for Pulsewave and Healthanywhere are active on the FDA website and are valid until 2013-12-31.
Concurrently, Biosign has listed Pulsewave Health Monitor packages on Amazon.com for purchase by US-based customers. As in Canada, initially two packages will be available: Pulsewave(TM) Personal ($199.00 USD + tax & shipping) is designed for one individual user, while Pulsewave(TM) Family ($229.00 USD + tax & shipping) is set up in such a way that up to five family members can share the use of one Pulsewave(TM) Pulse Acquisition Device (PAD). Each Pulsewave(TM) package includes the innovative Pulsewave(TM) device and one year of free access to a secure, encrypted online account where the each user's readings, charts & reports are accessible from any web browser. After the initial free year, a renewal fee of $23.99 USD/year (Personal) or $35.99 USD/year (Family) will be automatically billed to the user for continued access to readings & historical data. US shoppers can also purchase Pulsewave from store.biosign.com. Biosign intends to pre-position Pulsewave inventory in US for immediate fulfillment of US orders, in order to reduce shipping costs for US customers.
Biosign also announced an initial agreement to deploy the Healthanywhere Health Assist patient monitoring solution with AGAPE Global Outreach Inc. ("AGO") of Chicago IL. In Phase 1 of the project, AGO will deliver screening programs and provide "Linkage to Care" services within the state of Illinois using a Healthanywhere(TM) Health Assist mobile kiosk system as the screening / data capture system for their Health & Wellness program. Phase 2 of the project involves using up to 20 mobile Health Assist units to deliver remote monitoring services to individuals at high risk of health complications that were identified during Phase 1. AGO conducts health screenings, and provides health service referrals to members of disadvantaged communities throughout Illinois. The company intends use Healthanywhere Health Assist systems to reduce hospital readmissions and work with individuals to improve their health outcomes.
Biosign CEO Robert Kaul commented, "Biosign believes that our products have a role to play in the burgeoning US market for intelligent health information solutions. Now that both Pulsewave and Healthanywhere have received FDA 510(k) clearance, the completion of our Medical Establishment registration clears the way for an aggressive US sales effort during the balance of 2013 and beyond. We are pleased to be chosen as the vital sign monitoring technology partner for the AGO Linkage to Care project."
The Biosign Pulsewave(TM) Monitor is an end-to-end solution for non-invasive monitoring, analysis and reporting of health data. The Pulsewave(TM) cuff painlessly captures the pulse waveform from the subject's radial artery and transmits it to secure servers in the Cloud. Biosign algorithms are employed to analyze the data in seconds in order to generate reports that include blood pressure, heart beat anomalies and other vital sign measurements. Pulsewave(TM) is the only OTC health monitor that shows users the actual heart beating - live, in real-time. In addition, online Pulsewave(TM) analysis and reporting tools give patients and healthcare providers secure access to current and historical health information.
Healthanywhere(TM) is a clinical-grade patient monitoring platform that collects vital sign data from a variety of FDA-cleared medical devices including blood pressure cuffs, pulse oximeters, scales and glucose meters. For users, the gathering of vital signs is instantaneous and seamless; wireless automated bluetooth devices gather the data. For clinicians, we offer a powerful Clinical Portal where alerts, charts and printable reports can be accessed in a secure, encrypted cloud-based environment. Our smart-card enabled Healthanywhere(TM) Kiosk delivers easy, secure, convenient vital sign monitoring and tracking to public places such as pharmacies, employers and schools.
Contact Information for Biosign:
Robert Kaul
Chief Executive Officer
Biosign Technologies
Phone: (416) 218-9800 ext. 201
Email: ceo@biosign.com
About Biosign Technologies Inc:
Biosign Technologies Inc. (TSXV: BIO) provides automated, computer enabled health information products. Key applications include the noninvasive monitoring of vital signs including blood pressure, pulse rate and breathing rate, enhanced with web services. The Company's Pulsewave(TM) medical device technology powers data collection for clinical decision support, self-care, wellness and disease management, while its Healthanywhere(TM) software suite offers industry-leading remote patient monitoring solutions. The Company offers a number of cardiovascular screening programs for consumers under its Heart Friendly(TM) brand, including Heart Friendly(TM) Dentist. For more information on Biosign, please visit www.biosign.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
accesswire.com
Copyright 2013 ACCESSWIRE
News © Reuters Limited. Click for Restrictions.
Companies Mentioned
Symbol Last Change Volume
BIO 0.04 0.00 30,000
Trade Now
as of Jun 24, 2013 11:53 ET |
